Paul Perrotte

Université de Montréal, Henry Ford Health System

Papers

7

Total Citations

284

H-Index

6

About

Paul Perrotte is a leading urologic oncologist whose research has fundamentally shaped the modern surgical management of prostate and upper-tract urothelial cancers. His work centers on the comparative effectiveness and perioperative outcomes of robot-assisted surgery versus traditional open and laparoscopic approaches. Perrotte’s major contributions include demonstrating that robot-assisted radical prostatectomy (RARP) is safe and effective even in high-risk prostate cancer patients, challenging earlier assumptions about its limitations. His landmark 2012 study, cited over 90 times, revealed how regionalization and procedure volume differentially impact outcomes between robotic and open prostatectomy, providing critical evidence for surgical decision-making. He also led the first large-scale, population-based assessment comparing robotic versus laparoscopic nephroureterectomy, showing comparable perioperative outcomes with distinct cost implications—a study that has garnered over 50 citations. Beyond these, Perrotte has advanced understanding of pelvic lymph node dissection practices in the robotic era and validated seminal vesicle invasion nomograms through multi-institutional collaborations. His work has directly influenced clinical guidelines and helped define the evidence base for minimally invasive urologic oncology.

Research Focus

Key Achievements

6
H-Index
7
Papers
284
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Robot-Assisted Versus Open Radical Prostatectomy: The Differential Effect of Regionalization, Procedure Volume and Operative Approach
92 citations · 2012
📈 Most Prolific Year: 2014 (4 Papers)
🤝 Key Collaborators: 47
🏛 Institutions: Université de Montréal, Henry Ford Health System

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago